Backgound: Gastroesophageal reflux disease patients demonstrate various pathophysiologic backgrounds. Therefore, a heterogeneous response to proton-pump inhibitor (PPI) treatment can be expected. We investigated the effect of short-term PPI treatment on symptoms and quality of life (QOL) in primary care patients with and without pathologic esophageal acid exposure and in presence or absence of a positive association between symptoms and reflux episodes.Study: Seventy-four heartburn patients were categorized into 4 groups according to positive or negative symptom-reflux association, as expressed in symptom index, symptom sensitivity index, and symptom association probability (SAP) and presence or absence of pathologic reflux, defined as esop...
BACKGROUND:Gastro-esophageal reflux disease (GERD) is a common disease. It impairs health related qu...
Available data about reflux patterns and symptom determinants in the gastroesophageal reflux disease...
Abstract Background: A short-course of proton pump inhibitors (PPIs) is often used to confirm gastro...
Backgound: Gastroesophageal reflux disease patients demonstrate various pathophysiologic backgrounds...
Background: Refractory gastroesophageal reflux disease (GERD) may deteriorate patient quality of lif...
Introduction: Gastroesophageal reflux disease (GERD) is a highly prevalent condition in the Western ...
Background: The real size of the gastro-oesophageal reflux disease (GERD) population not responding ...
Background and Aim: Efficacy of proton pump inhibitors (PPIs) on symptoms of gastroesophageal reflux...
Objective: Although some patients may prefer using a particular kind of proton pump inhibitor in gas...
ABSTRACT BACKGROUND: Gastroesophageal reflux disease (GERD) is a clinical condition that develops ...
Introduction. Gastroesophageal reflux disease (GERD) is a common disease in primary care. The most ...
Background Inadequate response to proton pump inhibitor (PPI) therapy in patients with gastroesophag...
Background & Aims: The efficacy of proton-pump inhibitor (PPI) therapy often is assessed to determin...
Per the International Montreal Consensus, gastro-esophageal reflux disease (GERD) is defined as a c...
Proton pump inhibitors (PPIs) are nowadays the therapy of choice in the management of a variety of u...
BACKGROUND:Gastro-esophageal reflux disease (GERD) is a common disease. It impairs health related qu...
Available data about reflux patterns and symptom determinants in the gastroesophageal reflux disease...
Abstract Background: A short-course of proton pump inhibitors (PPIs) is often used to confirm gastro...
Backgound: Gastroesophageal reflux disease patients demonstrate various pathophysiologic backgrounds...
Background: Refractory gastroesophageal reflux disease (GERD) may deteriorate patient quality of lif...
Introduction: Gastroesophageal reflux disease (GERD) is a highly prevalent condition in the Western ...
Background: The real size of the gastro-oesophageal reflux disease (GERD) population not responding ...
Background and Aim: Efficacy of proton pump inhibitors (PPIs) on symptoms of gastroesophageal reflux...
Objective: Although some patients may prefer using a particular kind of proton pump inhibitor in gas...
ABSTRACT BACKGROUND: Gastroesophageal reflux disease (GERD) is a clinical condition that develops ...
Introduction. Gastroesophageal reflux disease (GERD) is a common disease in primary care. The most ...
Background Inadequate response to proton pump inhibitor (PPI) therapy in patients with gastroesophag...
Background & Aims: The efficacy of proton-pump inhibitor (PPI) therapy often is assessed to determin...
Per the International Montreal Consensus, gastro-esophageal reflux disease (GERD) is defined as a c...
Proton pump inhibitors (PPIs) are nowadays the therapy of choice in the management of a variety of u...
BACKGROUND:Gastro-esophageal reflux disease (GERD) is a common disease. It impairs health related qu...
Available data about reflux patterns and symptom determinants in the gastroesophageal reflux disease...
Abstract Background: A short-course of proton pump inhibitors (PPIs) is often used to confirm gastro...